Pulse 2.0 · 26 September 2023

Pulse 2.0 profiled Harmonix and its approach to backing data-driven platform companies across healthcare, life sciences and critical infrastructure. Maximilian Winter described how the firm grew out of his family office, and pointed to portfolio companies including Insilico Medicine, Volumetric and bit.bio as examples of the science the fund looks for.

“My journey with Harmonix started as a transition from my family office when I sought to diversify our business interests.”

Maximilian Winter, quoted in Pulse 2.0

Read the full article at Pulse 2.0 →